Pediatrics
 |
|
2 march 2021 09:49:27 |
| Study protocol: a multicenter, uncontrolled, open-label study of palivizumab in neonates, infants, and preschool children at high risk of severe respiratory syncytial virus infection (BMC Pediatrics) |
|
Tweet The prophylactic use of anti-respiratory syncytial virus (RSV) antibody (palivizumab) for severe RSV infection is not approved in Japan in specified groups of infants with neuromuscular diseases or other rare ... |
| 186 viewsCategory: Pediatrics |
 Lipid profile of Mexican children with Down syndrome (BMC Pediatrics)Recurrent variant c.1680C>A in FAM20C gene and genotype-phenotype correlation in a patient with Raine syndrome: a case report (BMC Pediatrics) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
